Cargando…
Relapsed Pulmonary Cryptococcosis during Tumor Necrosis Factor α Inhibitor Treatment
A 35-year-old non-HIV patient developed pulmonary cryptococcosis after the initiation of infliximab. He recovered by fluconazole treatment and completed the therapy for a total of 6 months. However, he experienced a relapse 16 months later during retreatment with infliximab, revealing an interesting...
Autores principales: | Takazono, Takahiro, Sawai, Toyomitsu, Tashiro, Masato, Saijo, Tomomi, Yamamoto, Kazuko, Imamura, Yoshifumi, Miyazaki, Taiga, Suyama, Naofumi, Izumikawa, Koichi, Kakeya, Hiroshi, Yanagihara, Katsunori, Mukae, Hiroshi, Kohno, Shigeru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088553/ https://www.ncbi.nlm.nih.gov/pubmed/27725552 |
Ejemplares similares
-
Recurrent Streptococcus agalactiae Toxic Shock Syndrome Triggered by a Tumor Necrosis Factor-α Inhibitor
por: Yoshida, Masataka, et al.
Publicado: (2016) -
Autophagy-Inducing Factor Atg1 Is Required for Virulence in the Pathogenic Fungus Candida glabrata
por: Shimamura, Shintaro, et al.
Publicado: (2019) -
Paradoxical response to disseminated non-tuberculosis mycobacteriosis treatment in a patient receiving tumor necrosis factor-α inhibitor: a case report
por: Takazono, Takahiro, et al.
Publicado: (2014) -
Vacuolar proton-translocating ATPase is required for antifungal resistance and virulence of Candida glabrata
por: Minematsu, Asuka, et al.
Publicado: (2019) -
Adjunctive corticosteroid therapy for inpatients with Mycoplasma pneumoniae pneumonia
por: Tashiro, Masato, et al.
Publicado: (2017)